Is all free time above the minimum inhibitory concentration the same: implications for β-lactam in vivo modelling-Reference-Cited by-同舟云学术

Is all free time above the minimum inhibitory concentration the same: implications for β-lactam in vivo modelling

Published:2007-03 Issue:3 Volume:29 Page:341-343
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

DeRyke C. Andrew,Nicolau David P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference7 articles.

1. Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model;Xuan;Antimicrob Agents Chemother,2002

2. Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004);Rhomberg;J Chemother,2005

3. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Fifteenth Informational Supplement. Document M100-S15. Wayne, PA: CLSI; 2005.

4. Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects;Musson;Antimicrob Agents Chemother,2004

5. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians;Nix;J Antimicrob Chemother,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosage Adjustment for Ceftazidime in Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic Modeling;Journal of Pharmaceutical Sciences;2021-04

2. Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282;ACS Infectious Diseases;2020-05-07

3. Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants;International Journal of Antimicrobial Agents;2019-03

4. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants;Antimicrobial Agents and Chemotherapy;2018-04

5. Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients;Antimicrobial Agents and Chemotherapy;2016-08-08